Ligand-mediated structural modulation and membrane stabilization of LPA1 receptor: Insights from molecular dynamics simulations
- Yahui Zhang 1, Mengxia Zhao 1, Yiru Wang 1, Yanyan Zhu 1, Yujie Chen 1, Li Chen 1, Huiyu Li 1
- Yahui Zhang 1, Mengxia Zhao 1, Yiru Wang 1
- 1College of Mathematics and Physics, Shanghai University of Electric Power, China.
- 0College of Mathematics and Physics, Shanghai University of Electric Power, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study reveals how ONO-0740556 and cryptoxanthin alter the structure of LPA1 receptors in cell membranes. Cryptoxanthin shows a stronger effect, suggesting potential for new drug development against LPA1-related diseases.
Area Of Science
- Biochemistry and Molecular Biology
- Pharmacology
- Computational Biology
Background
- Lysophosphatidic acid (LPA) signaling via LPA1 receptors is crucial in diseases like cancer and fibrosis.
- Understanding LPA1 modulation in its native membrane environment is key for therapeutic development.
- Traditional Chinese Medicine offers potential natural inhibitors, such as cryptoxanthin from Salvia miltiorrhiza.
Purpose Of The Study
- To compare the effects of ONO-0740556 and cryptoxanthin on LPA1 structure within a membrane environment.
- To provide atomic-level insights into LPA1 modulation by small molecules.
- To explore natural compounds as potential LPA1 inhibitors.
Main Methods
- Microsecond-scale all-atom molecular dynamics simulations.
- Systematic comparison of ligand-induced structural changes in LPA1.
- Analysis of receptor-membrane and intra-receptor interactions.
Main Results
- Both ONO-0740556 and cryptoxanthin enlarge the LPA1 binding channel entrance and weaken TM7 interactions.
- Both ligands reduce LPA1-membrane hydrophobic interactions, causing membrane perturbations.
- Cryptoxanthin demonstrates a more significant impact on channel widening and TM7 interactions.
Conclusions
- Small molecules can allosterically modulate LPA1 structure and dynamics in a membrane environment.
- Cryptoxanthin shows promise as a natural LPA1 inhibitor, offering a basis for drug design.
- Findings support the development of targeted therapies for LPA1-mediated diseases using natural products.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

